High-throughput peptide library synthesis is revolutionizing drug discovery by enabling the rapid generation and screening of large peptide collections. Our advanced platform can synthesize up to 800 unique peptides in parallel, dramatically accelerating hit identification and lead optimization timelines.
Peptide libraries are essential tools for epitope mapping, drug discovery, and binding studies. We offer both positional scanning libraries (where each position is systematically varied) and random libraries (where sequences are generated combinatorially). Libraries can be synthesized in 96-well or 384-well formats, with high reproducibility and minimal material consumption.
Our high-throughput synthesis platform employs state-of-the-art automated synthesizers and split-and-pool technologies to generate diverse libraries with controlled complexity. Each peptide is quality-controlled by MALDI-TOF and HPLC, with data delivered in a searchable format that facilitates downstream biological assays and SAR analysis.
Applications of our peptide libraries include receptor binding studies, enzyme substrate identification, antimicrobial peptide discovery, and immunology research. For pharmaceutical companies, these libraries provide a rapid path to identifying lead compounds for further optimization. For academic researchers, they offer access to diverse peptide collections that would be impractical to synthesize individually.
The integration of high-throughput synthesis with AI-driven design is further accelerating discovery timelines. By combining our synthesis capabilities with machine learning algorithms that predict peptide properties, we can guide library design toward regions of chemical space most likely to yield active compounds. This integrated approach represents the future of peptide drug discovery, enabling faster, more efficient identification of therapeutic candidates.